2-Deoxy-D-Glucose active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, On
Published April 29, 2015 · Recall initiated: November 14, 2014
Summary
FDA records drug Class II recall D-493-2015, published April 29, 2015 and initiated November 14, 2014. Recalling firm: Attix Pharmaceuticals; Status: Terminated; Reported quantity: 3100 grams; Lot: All lots repackaged and distributed between 01/05/12 to 02/12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Attix Pharmaceuticals
- Distributor
- Nationwide to compounding pharmacies and research organizations.
- Lot
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAMethyl 5-Aminolevulinate Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg inApril 29, 2015
- FDAHomatropine Methylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums,April 29, 2015
- FDAMethyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
- FDAPancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
- FDA4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
- FDA2-Methoxyestradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
Questions about this recall
Was 2-Deoxy-D-Glucose active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, On recalled?
Yes. FDA published recall D-493-2015 on April 29, 2015. Reported hazard: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit